Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastasis From Malignant Tumor of Prostate”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00005848
What this trial is testing

R115777 in Treating Patients With Progressive, Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy

Who this might be right for
Prostate Cancer
Fox Chase Cancer Center 7
Testing effectiveness (Phase 2)Study completedNCT00136526
What this trial is testing

Docetaxel and Diethylstilbestrol in the Treatment of Androgen Independent Prostate Cancer

Who this might be right for
Prostate Cancer
University of Washington 30
Testing effectiveness (Phase 2)Study completedNCT01630590
What this trial is testing

Cabozantinib and Androgen Ablation in Patients With Androgen-Dependent Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
M.D. Anderson Cancer Center 62
Early research (Phase 1)UnknownNCT00441571
What this trial is testing

Safety Study of a Radiolabeled Antibody (7E11) in Patients With Progressive Hormone Refractory Prostate Cancer

Who this might be right for
Metastatic Prostate Cancer
Cytogen Corporation 30
Testing effectiveness (Phase 2)Looking for participantsNCT05656794
What this trial is testing

Consolidative Prostate Radiotherapy in Metastatic Prostate Cancer

Who this might be right for
Prostate Metastases
University Health Network, Toronto 40
Testing effectiveness (Phase 2)Active Not RecruitingNCT00544830
What this trial is testing

Hormone Therapy and Intensity-Modulated Radiation Therapy in Treating Patients With Metastatic Prostate Cancer

Who this might be right for
PSA Level Greater Than TwoStage IV Prostate Adenocarcinoma AJCC v7
City of Hope Medical Center 29
Testing effectiveness (Phase 2)Active Not RecruitingNCT03902951
What this trial is testing

Antiandrogen Therapy and SBRT in Treating Patients With Recurrent, Metastatic Prostate Cancer

Who this might be right for
Metastatic Prostate AdenocarcinomaProstate Adenocarcinoma With Focal Neuroendocrine DifferentiationRecurrent Prostate Carcinoma+1 more
Jonsson Comprehensive Cancer Center 28
Testing effectiveness (Phase 2)Study completedNCT00055471
What this trial is testing

A Phase IIa. Open-label, Multicenter, Dose-escalation Study to Assess the Tolerability and Pharmacokinetics of ZD4054 (Zibotentan) Given Orally Once Daily in Subjects With Metastatic Prostate Cancer

Who this might be right for
Prostatic NeoplasmsMetastases, Neoplasm
AstraZeneca 22
Not applicableUnknownNCT02963155
What this trial is testing

Study of Natural Killer Cells in Patients With Metastatic Prostate Cancer: Relationship With Survival and Response Time to Castration

Who this might be right for
Metastatic Prostate Cancer
Institut Paoli-Calmettes 30
Early research (Phase 1)Ended earlyNCT03041285
What this trial is testing

Idronoxil Suppository Combine With Radiotherapy for Metastatic Prostate Cancer

Who this might be right for
Metastatic Castrate- Resistant Prostate Cancer
Royal North Shore Hospital 1
Testing effectiveness (Phase 2)Active Not RecruitingNCT03763253
What this trial is testing

Additional Treatments to the Local Tumour for Metastatic Prostate Cancer: Assessment of Novel Treatment Algorithms

Who this might be right for
Prostate CancerMetastatic Prostate Cancer
Imperial College London 433
Not applicableWithdrawnNCT05156372
What this trial is testing

Adjuvant High-intensity Interval Training During Chemotherapy in Metastatic Prostate Cancer Patients

Who this might be right for
Prostate Cancer MetastaticCastrate Resistant Prostate CancerMetastatic Prostate Cancer+1 more
The University of Texas Health Science Center at San Antonio
Large-scale testing (Phase 3)UnknownNCT04026230
What this trial is testing

Impact of Atorvastatin on Prostate Cancer Progression During ADT

Who this might be right for
Metastatic Prostate CancerRecurrent Prostate Cancer
Tampere University Hospital 400
Early research (Phase 1)Study completedNCT00064129
What this trial is testing

Ipilimumab and Sargramostim in Treating Patients With Metastatic Prostate Cancer

Who this might be right for
Recurrent Prostate CarcinomaStage IV Prostate Cancer AJCC v7
National Cancer Institute (NCI) 42
Testing effectiveness (Phase 2)Study completedNCT00087139
What this trial is testing

Ixabepilone in Treating Patients With Metastatic Prostate Cancer

Who this might be right for
Adenocarcinoma of the ProstateRecurrent Prostate CancerStage IV Prostate Cancer
National Cancer Institute (NCI) 124
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07838753
What this trial is testing

A Study Testing if Patients With Advanced Prostate Cancer Who Are Responding Well to Combination Treatment Can Safely Reduce Their Medication to a Single Hormone Therapy, Compared to Continuing Their Current Drugs

Who this might be right for
Castration Sensitive Prostate CancerMetastatic Prostate Cancer
Kokilaben Dheerubhai Ambani Hospital and Research 170
Not applicableActive Not RecruitingNCT07721532
What this trial is testing

Observing the Real-world Non-interventional Study of Abiraterone Acetate Tablets (II) in Treating Chinese Patients With Metastatic Prostate Cancer

Who this might be right for
Diagnosed With Metastatic Prostate Cancer
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 3,000
Testing effectiveness (Phase 2)Study completedNCT02815033
What this trial is testing

Imaging Staging and Response Prediction in Metastatic Hormono-Sensitive Prostate Cancer Patients Receiving Enzalutamide

Who this might be right for
Prostate Cancer Metastatic
The European Uro-Oncology Group 66
Early research (Phase 1)Ended earlyNCT02500901
What this trial is testing

Enzalutamide and Niraparib in the Treatment of Metastatic Castrate-Resistant Prostate Cancer (CRPC)

Who this might be right for
Metastatic Prostate Cancer
Paul Mathew, MD 2
Not applicableStudy completedNCT04049747
What this trial is testing

Comparative Health Research Outcomes of NOvel Surgery in Prostate Cancer

Who this might be right for
Prostate CancerNon-metastatic Prostate CancerProstate Adenocarcinoma
Imperial College London 100
Next Page